Status:
COMPLETED
QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This observational pilot prospective study will evaluate a new method for remote monitoring of corrected QT measurement using an artificial intelligence (AI)-based solution and ECG data collected via ...
Eligibility Criteria
Inclusion
- Patient over 18 years old
- SARS-COV-2 confirmed infection by positive nasopharyngual PCR
- Prescription of association hydroxychloroquine and azythromycine for COVI-19 therapy
- Patient's smartphone able to download the smartwatches application
Exclusion
- Presence of a pacemaker
- Pregnant or breastfeeding females
- Refusal to participate
- Incapacity
- Adult under legal protection (trusteeship, guardianship)
Key Trial Info
Start Date :
April 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 5 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04371744
Start Date
April 17 2020
End Date
June 5 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France, 13005